ACB $6.530 (-5.22%)

ACNNF $0.112 (0%)

AERO $3.135 (-3.83%)

AGEEF $0.063 (-3.09%)

ALEAF $0.389 (-0.23%)

AMMJ $0.073 (-2.28%)

APHA $4.680 (0.43%)

ARNA $71.250 (0.95%)

ATT:CNX $0.080 (0%)

ATTBF $0.007 (2.33%)

AUSA:CNX $0.155 (6.9%)

AUSAF $0.123 (0%)

AVXL $4.250 (1.43%)

BAMM:CNX $0.390 (2.63%)

BBM:CNX $0.055 (10%)

BBRRF $0.040 (4.58%)

BE:CNX $0.005 (0%)

BIO:CNX $0.070 (16.67%)

BLEVF $0.004 (26.67%)

BLIS:CNX $0.315 (0%)

BLO:CNX $0.430 (-8.51%)

BLOZF $0.330 (-5.71%)

BUDZ $0.200 (-4.76%)

BXNG $0.440 (0%)

CADMF $0.633 (-4.99%)

CALI:CNX $0.070 (0%)

CANN $0.318 (5.83%)

CARA $14.530 (-1.62%)

CBII:CNX $0.190 (2.7%)

CBIIF $0.144 (1.74%)

CBWTF $0.110 (-6.38%)

CGC $16.360 (-0.24%)

CGRW $0.084 (9.09%)

CHOO:CNX $0.090 (-5.26%)

CHOOF $0.067 (-5.91%)

CNBX $0.175 (1.72%)

CNGGF $0.270 (0%)

CODI $17.700 (0.45%)

CPMD $0.650 (1.58%)

CRBP $1.900 (-3.06%)

CRON $5.290 (0.95%)

CROP:CNX $0.015 (0%)

CRTPF $2.300 (-9.95%)

CRXPF $0.050 (46.55%)

CSI:CNX $0.920 (0%)

CURR $1.440 (-3.36%)

CVSI $0.530 (3.33%)

DIGP $0.026 (1.37%)

DXBRF $0.140 (0%)

EAPH $0.001 (0%)

EAT:CNX $0.015 (50%)

EEVVF $0.054 (2.45%)

EMHTF $0.151 (-5.63%)

EPWCF $0.034 (-4.72%)

EVIO $0.017 (12.67%)

FFRMF $0.025 (0.2%)

FFT:CNX $0.040 (0%)

FNNZF $0.053 (0%)

GGTTF $0.060 (-17.15%)

GLDFF $0.017 (-4.55%)

GLH:CNX $0.020 (0%)

GNBT $0.247 (5.11%)

GRIN:CNX $0.110 (4.76%)

GRWG $15.970 (1.62%)

GSTR:CNX $0.050 (-9.09%)

GTBIF $14.100 (-0.35%)

GTII:CNX $18.620 (-0.05%)

GWPH $100.180 (-1.79%)

HEXO $0.774 (1.78%)

HLSPY $0.385 (0%)

HMLSF $4.655 (-1.58%)

HMPPF $0.498 (0%)

HRVOF $0.050 (-10.07%)

HSTRF $0.084 (5.41%)

HUGE:CNX $3.640 (-2.93%)

IAN:CNX $0.090 (0%)

IGC $1.190 (0%)

IGXT $0.150 (-1.24%)

IIPR $124.790 (-1.1%)

IMLFF $3.678 (-1.14%)

INQD $0.003 (0%)

IONC:CNX $0.015 (0%)

IONKF $0.015 (-28.57%)

ISOL:CNX $0.035 (16.67%)

ISOLF $0.030 (34.53%)

ITHUF $0.072 (-5.3%)

IVITF $0.007 (84.21%)

JWCAF $0.004 (0%)

KBEV:CNX $0.060 (0%)

KBEVF $0.041 (-7.22%)

KHRNF $0.359 (-2.93%)

KSHB $0.470 (1.73%)

LHS:CNX $0.510 (-1.92%)

LHSIF $0.396 (0.76%)

LOVE:CNX $0.090 (0%)

LXRP $0.265 (-2.48%)

LXX:CNX $0.345 (-1.43%)

MCIG $0.028 (0%)

MEDIF $0.676 (-2.55%)

MGWFF $0.051 (-9.94%)

MICWF $0.079 (0%)

MJ:CNX $0.035 (0%)

MJNA $0.014 (0.36%)

MNTR $0.080 (-2.38%)

MRRCF $0.004 (5.88%)

MWM:CNX $0.095 (0%)

MYM:CNX $0.055 (-8.33%)

MYMMF $0.041 (-12.21%)

NCNNF $0.140 (6.87%)

NDVAF $0.186 (-5.11%)

NGW:CNX $0.215 (-2.27%)

NRXCF $0.093 (-8.79%)

NSPDF $0.049 (-3.07%)

NTEC $0.283 (0.86%)

NVTQF $0.451 (0%)

NWKRF $0.424 (0%)

NXGWF $0.165 (-0.93%)

NXTTF $0.187 (-0.21%)

OH:CNX $5.330 (0%)

ORHOF $4.050 (0%)

OWCP $0.009 (-0.56%)

PHCG $0.500 (0%)

PHVAF $0.038 (-5.71%)

PILL:CNX $0.650 (0%)

PKG:CNX $0.075 (-6.25%)

PLPRF $0.460 (-2.56%)

PLUS:CNX $0.610 (-1.61%)

PMCB $0.011 (-7.89%)

PNPL $0.200 (0%)

POTN $0.014 (5.19%)

PRCNF $0.008 (-15.79%)

PTNYF $0.055 (-3.74%)

QCA:CNX $0.125 (4.17%)

RDDTF $0.082 (-11.54%)

RLLVF $0.041 (-30.51%)

RMHB $0.053 (1.92%)

RQB:CNX $0.005 (0%)

RQHTF $0.181 (1.68%)

RVVQF $0.007 (-12.5%)

SLNG:CNX $0.135 (3.85%)

SMG $149.130 (-3.63%)

SNN:CNX $0.155 (0%)

SNNVF $0.115 (15%)

SOL:CNX $1.050 (2.94%)

SOLCF $0.747 (-1.76%)

SPLIF $0.012 (14.5%)

SPRWF $0.115 (-3.69%)

SRNA $0.023 (-0.44%)

STEM:CNX $0.340 (11.48%)

STMH $0.260 (8.33%)

SUN:CNX $0.150 (-14.29%)

TBPMF $0.131 (0%)

TCAN:CNX $0.930 (-1.06%)

TCNAF $0.708 (0%)

TER:CNX $6.000 (0%)

TGEN $0.752 (-4.86%)

TGIF:CNX $0.060 (0%)

TGIFF $0.045 (-3.62%)

THC:CNX $0.140 (-3.45%)

THCBF $0.106 (-3.64%)

TLRY $5.340 (-1.66%)

TOKI:CNX $0.030 (0%)

TRLFF $0.027 (8%)

TRSSF $4.530 (-0.22%)

TRTC $0.073 (2.16%)

TURV $0.117 (-10.28%)

VBIO $0.160 (-20%)

VIDA:CNX $0.055 (0%)

VIN:CNX $0.015 (0%)

VPRB $0.023 (4.55%)

VRNDF $0.443 (0%)

VRT:CNX $0.150 (0%)

VRTHF $0.115 (0%)

VVCIF $0.152 (0.76%)

WAYL:CNX $0.740 (0%)

WDDMF $0.243 (-7.72%)

WLDFF $0.120 (0.5%)

XXII $0.570 (-2.11%)

ZDPY $0.225 (-6.25%)

ZYNE $3.700 (-2.63%)

Technical420 Site Search

Returned 33 result(s).

Cardiol Therapeutics To Benefit On The Rescheduling Of GW Pharma’s Epidiolex By The DEA

Earlier this year, the Drug Enforcement Administration (DEA) announced a significant development for patients who need to access Epidiolex, the only federally approved drug derived from cannabis. Epidiolex is manufactured and sold by GW Pharmaceuticals (GWPH) and is no longer considered to be a controlled substance under the Controlled Substances…

The DEA Wants To Study The Medical Benefits Of Cannabis, But The DOJ Is Stonewalling Them

Although CNN reported that a study found little evidence that marijuana helps treat chronic pain and PTSD, we beg to differ…Two studies published in the journal Annals of Internal Medicine found that there was little scientific evidence to support either the effectiveness or safety of medical marijuana.If Marijuana is Dangerous,…

#Breaking: FDA Declares CBD Beneficial

Yesterday, the FDA called for comments to help the United Nation’s World Health Organization (WHO) decide whether 17 controversial drugs should face international restrictions under the 1971 Convention on Psychotropic Substances.Out of the listed substances, cannabidiol (CBD) was the only one that the FDA called beneficial. The agency issued the…

This Is How The “Marijuana Justice Act” Will Reshape The War On Drugs

Derek Thomas – Political AnalystSenator Cory Booker, one of the nations youngest Senators, and one of only two African-Americans in Congress, introduced a bill in the Senate yesterday which would cement Senator Booker a permanent spot in the hearts and memories of cannabis history.Booker, a democrat from New Jersey, choose…

BREAKING NEWS – The DEA Quietly Renews the Fight Against CBD and Cannabis

Derek Thomas – Political AnalystThere are so many fronts in the war for marijuana legalization that it’s an arduous task to monitor all of them, yet the job has never been more important. And Last month, the Drug Enforcement Administration stealthy over-stepped its boundaries (again) and advanced its prohibitionist agenda.…

The New(ish) Sheriff In Town Hates Your Weed – Will DEA Administrator Chuck Rosenberg remain at the DEA?

Derek Thomas – Political AnalystSix months into the Trump administration and a lot of remaining Obama appointees have been replaced. Some fairly routine, like ambassadors, the surgeon general, some US district Attorney’s US Attorneys. Some more inflammatory like an FBI Director. And many posts either remain vacant or occupied by…

“Cannabis Supporters Be Warned” – The DOJ is going to eviscerate lenient sentencing laws.

Derek Thomas – Political AnalystA recent article published by the Associated Press highlights the Justice Departments intention to roll back Eric Holder’s Justice Department era policies of reduced sentences for first time offenders, non-violent offenders, and people detained with smaller amounts of narcotics.This could spell big trouble for marijuana enthusiasts…

DEA Chief: “Marijuana is not medicine.”

These senseless comments come from Chuck Rosenberg, the acting chief of the Drug Enforcement Administration (DEA) during a speech at an Ohio hospital.Rosenberg said, “If it turns out that there is something in smoked marijuana that helps people, that’s awesome. I will be the last person to stand in the…

How Cannabis and Hemp are Changing the World and Saving Lives

The only reason why marijuana is illegal is because of economics. If marijuana was legal, it would cost pharmaceutical and alcohol companies billions of dollars every year. Last year, the DEA decided to keep cannabis classified as a Schedule I substance along with drugs like heroin, peyote, LSD, bath salts, ecstasy,…

It is official…Marijuana is Safer than Heroin.

Yesterday, Chuck Rosenberg, who is the new head of the Drug Enforcement Agency (DEA), made the following statement at the agency’s headquarters.  “Heroin is clearly more dangerous than marijuana.”Last week, Rosenberg said marijuana is probably not as dangerous as heroin and the press had a field day over his statement.…

Older Posts »

Search Again